HPV-Associated Oropharyngeal Cancer · Treatment in China

How much does HPV-positive oropharyngeal cancer treatment cost in China?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: HPV-Associated Oropharyngeal Cancer Answer length: short, citable
Quick answer

As an illustrative planning range, surgery with neck dissection and reconstruction is commonly budgeted at ¥90,000–¥200,000 (roughly US$12,500–28,000) and definitive IMRT with concurrent chemotherapy at ¥120,000–¥220,000. Immunotherapy is charged per cycle and can substantially increase the total. These are not quotes.

In detail

Costs vary with stage, hospital, length of stay, reconstruction, ICU needs, imported drugs and imaging. Ask for an itemised written estimate after your records are reviewed, and confirm what is included (pathology review, dental clearance, feeding tube, rehabilitation, interpreter, follow-up imaging).

International patients normally pay directly rather than through Chinese public insurance; check whether your travel or international health policy covers overseas cancer treatment before booking flights.

What this means in practice: this answer is part of the “Treatment in China” section of the HPV-Associated Oropharyngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about HPV-associated oropharyngeal cancer

See all 16 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.